2-Bromo-4-cyanopyridine | CAS:10386-27-3

We serve 2-Bromo-4-cyanopyridine CAS:10386-27-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-4-cyanopyridine

Chemical Name:2-Bromo-4-cyanopyridine
CAS.NO:10386-27-3
Synonyms:2-bromopyridine-4-carbonitrile; 
2-Bromoisonicotinonitrile; 
2-Bromo-4-Cyanopyridine;
 
Molecular Formula:C6H3BrN2
Molecular Weight:183.00500
 
Physical and Chemical Properties:
Density:1.72;
Melting point:78-80oC;
Boiling point:243.4oC;
Flash point:101oC;
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Bromo-4-cyanopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-4-Cyanopyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-4-cyanopyridine Use and application,2-Bromoisonicotinonitrile technical grade,usp/ep/jp grade.


Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.2-(3-Bromophenyl)-4,6-diphenyl-1,3,5-triazine manufacturer Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country.2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide supplier Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country.4-(2-Chloroethyl)morpholine hydrochloride vendor The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.